Effect of transverse thoracic muscle plane block on perioperative period of patients undergoing cardiac surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024933

Enrollment

Unknown

Registered

2019-08-04

Start date

2019-08-30

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery Patients

Interventions

experimental group:bilateral transversus thoracis muscle plane

control group:intravenous analgesia

Eligibility

Sex/Gender

All

Age

1 Years to 78 Years

Inclusion criteria

Inclusion criteria: Selective patients undergoing cardiac surgery with ASA II-III and NYHA II-III grading of cardiac function.

Exclusion criteria

Exclusion criteria: Patients refused, liver and kidney dysfunction, chest deformity could not be performed nerve block, left ventricular ejection fraction < 30%. Postoperative cognitive dysfunction.

Design outcomes

Primary

Measure	Time frame
VAS score within 48 hours;Postoperative ICU retention time;Postoperative nausea and vomiting;Postoperative exhaust time;Postoperative defecation time;Hospitalization days;	—

Secondary

Measure	Time frame
Total dosage of sufentanil during perioperative period;Postoperative mechanical ventilation time;Drainage tube removal time;	—

Countries

China

Contacts

Public ContactHaixia Gong

The First Affiliated Hospital of Nanchang University

13870981388@139.com+86 13870891388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026